Home Owlstone Medical

Owlstone Medical

Owlstone Medical to Join EU-Funded EPHOR Consortium

The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual.

Owlstone Medical Partners with Thermo Fisher Scientific

The collaboration seeks to advance the application of non-invasive breath sampling to address the challenges of the early detection of disease and the precision medicine delivery of healthcare through the discovery and validation of novel biomarkers

Breath Biopsy Kits Launched by Owlstone Medical

3/28/18: Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine

Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Owlstone Medical, (diagnostics company developing a breathalyzer for disease), today announced the initiation of the PAN Cancer...

Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal

Billy Boyle, Founder and CEO of Owlstone Medical, (a diagnostics company developing a breathalyzer for disease), is...

Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder

Billy Boyle, co-founder and CEO at Owlstone Medical, commented: “With over four decades’ work in cancer research...

Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy

Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100%...